SEC Form 4 · accession 0001209191-17-060431
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven St Peter
Officer — PRESIDENT AND CEO · Director
Period of report
Nov 10, 2017
Accepted (ET)
Nov 13, 2017 · 6:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 10, 2017 | S | 50,000 | $7.00 | D | 529,359 | D | |
| Common StockF2 | holding | — | — | — | 86,997 | I | By LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person.
- F2Held in the name of Vie Venture LLC, a Delaware limited liability company ("Vie Venture"). The Reporting Person has sole voting and dispositive power over the shares held by Vie Venture, but disclaims beneficial ownership of the shares held thereby except to the extent of his pecuniary interest therein.